DrugPatentWatch Database Preview
Neos Theraps Company Profile
What is the competitive landscape for NEOS THERAPS, and what generic alternatives to NEOS THERAPS drugs are available?
NEOS THERAPS has three approved drugs.
There are six US patents protecting NEOS THERAPS drugs.
There are two patent family members on NEOS THERAPS drugs in two countries.
Summary for Neos Theraps
| International Patents: | 2 |
| US Patents: | 6 |
| Tradenames: | 3 |
| Ingredients: | 2 |
| NDAs: | 3 |
Drugs and US Patents for Neos Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neos Theraps Inc | ADZENYS ER | amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 204325-001 | Sep 15, 2017 | RX | Yes | Yes | 9,265,737 | See Pricing | Y | See Pricing | |||
| Neos Theraps | ADZENYS XR-ODT | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 204326-001 | Jan 27, 2016 | RX | Yes | No | 8,709,491 | See Pricing | Y | See Pricing | |||
| Neos Theraps | ADZENYS XR-ODT | amphetamine | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 204326-004 | Jan 27, 2016 | RX | Yes | No | 9,017,731 | See Pricing | Y | See Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neos Theraps Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2013003622 | See Pricing |
| European Patent Office | 2726066 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
